share_log

Evelo Biosciences Is a Clinical-Stage Biotechnology Company

Dow Jones Newswires ·  Jan 29, 2021 10:13

*DJ Evelo Biosciences Prices Offering of 4.5M Shares at $15 Each

(MORE TO FOLLOW) Dow Jones Newswires

January 28, 2021 21:09 ET (02:09 GMT)

*DJ Evelo Biosciences Underwriters Can Buy Up to 675,000 More Shares to Cover Overallotments

(MORE TO FOLLOW) Dow Jones Newswires

January 28, 2021 21:10 ET (02:10 GMT)

*DJ Evelo Biosciences Expects Gross Proceeds of $67.5M

(MORE TO FOLLOW) Dow Jones Newswires

January 28, 2021 21:11 ET (02:11 GMT)

*DJ Morgan Stanley, Cowen, BMO Capital Markets Are Bookrunners for Evelo Biosciences Offering

(MORE TO FOLLOW) Dow Jones Newswires

January 28, 2021 21:12 ET (02:12 GMT)

*DJ Evelo Biosciences Is a Clinical-Stage Biotechnology Company

(END) Dow Jones Newswires

January 28, 2021 21:13 ET (02:13 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment